v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 155,500 $ 155,714
Equity method investments 2,563,948 1,869,712
Receivables 2,799,000  
Receivables held-for-sale 16,660 85,254
Real estate 111,249 353,000
Investments 9,370 10,200
Securitization assets, net of allowance of $3 million and $0, respectively 182,824 177,032
Other assets 69,253 119,242
Total Assets 5,908,144 4,760,148
Liabilities:    
Accounts payable, accrued expenses and other 150,584 120,114
Credit facilities 486,724 50,698
Commercial paper notes 49,974 192
Term loans payable 567,244 379,742
Senior unsecured notes 1,782,197 1,767,647
Convertible notes 603,905 344,253
Total Liabilities 3,808,250 3,095,402
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 111,167,157 and 90,837,008 shares issued and outstanding, respectively 1,112 908
Additional Paid in Capital, Common Stock 2,353,453 1,924,200
Accumulated deficit (348,929) (285,474)
Accumulated other comprehensive income (loss) 47,264 (10,397)
Non-controlling interest 46,994 35,509
Total Stockholders’ Equity 2,099,894 1,664,746
Total Liabilities and Stockholders’ Equity 5,908,144 4,760,148
Non-recourse debt    
Liabilities:    
Non-recourse debt (secured by assets of $245 million and $632 million, respectively) 167,622 432,756
Commercial receivables    
Assets    
Receivables 2,705,976 1,887,483
Government receivables    
Assets    
Receivables $ 93,364 $ 102,511

Source